COMP <GO>
BLCO vs UNH // 10Y YIELD & FRED MACRO BETA
Bausch + Lomb Corporation (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: BLCO 3
— UNH 12
▲ 10Y YIELD & FRED MACRO BETA LEADER: BLCO
LAST: $20.00 (-1.96%) • MKT CAP: $7.29B
macro-sensitivity
1.06
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
macro-sensitivity
0.33
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BLCO VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BLCO | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 88.57% | -47.57 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.80% | 11.47% | -10.67 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 29.1x | 16.4x | +12.65 | UNH | /valuation <GO> |
| Free Cash Flow Yield | -0.90% | 6.48% | -7.38 | UNH | /fcf-yield <GO> |
| Operating Margin | 2.20% | 4.82% | -2.62 | UNH | /operating-margins <GO> |
| Net Profit Margin | -7.10% | 3.14% | -10.24 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 6.50% | 6.46% | +0.04 | BLCO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.97 | 3.12 | -2.15 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 6.74% | +0.36 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 73.8 | 56.0 | +17.80 | BLCO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.06 | 0.33 | +0.73 | BLCO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.0x | 17.1x | +5.91 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.29B | $364.66B | -$357.37B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BLCO REV | UNH REV | BLCO GROSS % | UNH GROSS % | BLCO FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.10B | $447.57B | 44.0% | 88.7% | -$66.0M | $16.07B |
| FY 2024 | $4.79B | $400.28B | 44.0% | 88.3% | -$59.0M | $20.70B |
| FY 2023 | $4.15B | $371.62B | 44.0% | 89.6% | -$203.6M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BLCO // BETA 1.06
UNH // BETA 0.33